当前位置: X-MOL 学术Lancet Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Androgen deprivation therapy for prostate cancer
The Lancet Oncology ( IF 51.1 ) Pub Date : 2017-09-01 , DOI: 10.1016/s1470-2045(17)30670-8
Manjulika Das

Androgen deprivation therapy (ADT) for localised prostate cancer is associated with an increased risk of cardiac failure and other cardiac dysfunction, a new study has found. However, another study of ADT in patients with prostate cancer has shown that ADT does not increase the risk of Alzheimer's disease.

中文翻译:

雄激素剥夺治疗前列腺癌

一项新的研究发现,用于局部前列腺癌的雄激素剥夺疗法(ADT)与心力衰竭和其他心脏功能障碍的风险增加相关。但是,另一项对前列腺癌患者进行ADT的研究表明,ADT不会增加阿尔茨海默氏病的风险。
更新日期:2017-09-04
down
wechat
bug